title: Evidence for restrictive parameters in formulation of insulin-loaded nanocapsules.
abstract: Poly(isobutylcyanoacrylate) nanocapsules with an oily core were originally proposed for lipophilic drug encapsulation [Int. J. Pharm. 28 (1986) 125] but insulin, a hydrosoluble protein, has also been successfully encapsulated by Damgé et al. [Diabetes 37 (1988) 246]. The aim of this work was to understand if several parameters were restrictive for the encapsulation of insulin into the oily core of the nanocapsules prepared by interfacial polymerization. The encapsulation efficiency of insulin was not affected by the type of insulin since the peptides adopted the same association state after their addition to the organic phase. Formulation parameters mainly affected the size of the nanocapsules obtained but did not influence the insulin encapsulation efficiency. In contrast, the order of introduction of insulin and of the monomer in the organic phase was shown to control the formation and the characteristics of the nanocapsules. The key parameters, which were found to clearly influence the encapsulation efficiency of insulin, were the pH of the aqueous insulin solution and the origin of the monomer. Both of these parameters can affect the rate of the interfacial polymerization. Consequently, the ability of insulin to be entrapped into the oil containing nanocapsules appeared to be governed more by the rate of the monomer polymerization.
authors.affiliation: Laboratoire de Physico-chimie, Pharmacotechnie et Biopharmacie, Université Paris XI, Châtenay-Malabry, France.
authors.forename: Fabienne
authors.initials: F
authors.lastname: Cournarie
authors.forename: Monique
authors.initials: M
authors.lastname: Chéron
authors.forename: Madeleine
authors.initials: M
authors.lastname: Besnard
authors.forename: Christine
authors.initials: C
authors.lastname: Vauthier
mesh_terms: D000818:Animals; D002417:Cattle; D002626:Chemistry, Pharmaceutical; D006801:Humans; D007328:Insulin / Q000737:chemistry*; D036103:Nanotechnology / Q000592:standards*; D013678:Technology, Pharmaceutical / Q000592:standards*
chemical_list: D007328:Insulin